JILL BILEK, MD
Infectious Disease Physician · FORT LAUDERDALE, FL
Individual Active NPI 1497243331
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 246 | 586,245 | $3,735,348 | $1,236,292 | $984,264 |
| 2023 | 31 | 73,653 | $193,591 | $54,802 | $43,695 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0878 | Injection, daptomycin, 1 mg | 390,949 | $0 | $0 |
| J2185 | Injection, meropenem, 100 mg | 14,081 | $0 | $0 |
| J2406 | Injection, oritavancin (kimyrsa), 10 mg | 9,120 | $40 | $32 |
| J1306 | Injection, inclisiran, 1 mg | 5,396 | $12 | $10 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,688 | $0 | $0 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 2,008 | $59 | $47 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 1,974 | $1 | $1 |
| J1335 | Injection, ertapenem sodium, 500 mg | 1,434 | $11 | $9 |
| J0897 | Injection, denosumab, 1 mg | 900 | $26 | $21 |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 531 | $27 | $21 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 439 | $124 | $98 |
| J1201 | Injection, cetirizine hydrochloride, 0.5 mg | 400 | $15 | $12 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Infectious Disease Physician | 207RI0200X | ✓ | ME163315 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Infectious Disease Physician providers in Florida
- NPI 1508176587
- NPI 1992657134
- NPI 1710758164
- NPI 1992902753
- NPI 1144292384
- NPI 1326102252
- NPI 1346001807
- NPI 1407163728
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.